Death-domain associated protein-6 (DAXX) mediated apoptosis in hantavirus infection is counter-balanced by activation of interferon-stimulated nuclear transcription factors  by Khaiboullina, Svetlana F. et al.
Virology 443 (2013) 338–348Contents lists available at SciVerse ScienceDirectVirology0042-68
http://d
n Corr
E-mjournal homepage: www.elsevier.com/locate/yviroDeath-domain associated protein-6 (DAXX) mediated apoptosis in
hantavirus infection is counter-balanced by activation of
interferon-stimulated nuclear transcription factors
Svetlana F. Khaiboullina a,n, Sergey P. Morzunov b, Sergei V. Boichuk c, András Palotás d,
Stephen St. Jeor e, Vincent C. Lombardi a, Albert A. Rizvanov f
a Whittemore Peterson Institute, University of Nevada-Reno, Reno, USA
b Department of Pathology and Nevada State Health Laboratory, University of Nevada-Reno, Reno, USA
c Kazan State Medical University, Kazan, Russia
d Asklepios-Med (private medical practice and research center), Szeged, Hungary
e Department of Microbiology and Immunology, University of Nevada-Reno, Reno, USA
f Department of Genetics, Kazan (Volga Region) Federal University, Kazan, Russiaa r t i c l e i n f o
Article history:
Received 2 May 2013
Accepted 15 May 2013
Available online 3 July 2013
Keywords:
DAXX
Hantavirus
HUVEC
ISG-20
PML
Sp100
SUMO22/$ - see front matter Published by Elsevier
x.doi.org/10.1016/j.virol.2013.05.024
esponding author. Fax: +1 775682 8258.
ail address: sv.khaiboullina@gmail.com (S.F. Ka b s t r a c t
Hantaviruses are negative strand RNA species that replicate predominantly in the cytoplasm. They also
activate numerous cellular responses, but their involvement in nuclear processes is yet to be established.
Using human umbilical vein endothelial cells (HUVECs), this study investigates the molecular ﬁnger-print
of nuclear transcription factors during hantavirus infection. The viral-replication-dependent activation of
pro-myelocytic leukemia protein (PML) was followed by subsequent localization in nuclear bodies (NBs).
PML was also found in close proximity to activated Sp100 nuclear antigen and interferon-stimulated
gene 20 kDa protein (ISG-20), but co-localization with death-domain associated protein-6 (DAXX) was
not observed. These data demonstrate that hantavirus triggers PML activation and localization in NBs in
the absence of DAXX-PLM-NB co-localization. The results suggest that viral infection interferes with
DAXX-mediated apoptosis, and expression of interferon-activated Sp100 and ISG-20 proteins may
indicate intracellular intrinsic antiviral attempts.
Published by Elsevier Inc.Introduction
Hantaviruses are tri-segmented negative strand RNA micro-
organisms that belong to the family Bunyaviridae. The large (L),
medium (M), and small (S) genomic segments code for the viral
RNA dependent RNA polymerase (RdRp), the glycoprotein precur-
sor (GPC) of the 2 envelope glycoproteins (G1 and G2), and the
nucleocapsid protein (N), respectively. Hantavirus replication
occurs entirely in the cytoplasm. Shortly after virus entry and
uncoating, the RdRp initiates positive strand mRNA synthesis from
the genomic L, M and S RNAs (vRNAs) using a cap-snatching
mechanism (Dunn et al., 1995; Garcin et al., 1995; Kolakofsky and
Hacker 1991).
In postmortem tissues, hantaviruses are primarily found in
endothelial cells, suggesting a cellular tropism essential for hanta-
virus pathogenesis (Zaki et al., 1995; Zhang et al., 1987). This
hypothesis is further supported by in vitro studies that showInc.
haiboullina).endothelial cells are uniquely susceptible to hantavirus infection
and support virus replication (Khaiboullina et al., 2000; Pensiero
et al., 1992). Our group, as well as others, has shown that
hantavirus infection activates speciﬁc cellular responses in
endothelial cells (Khaiboullina et al., 2004; Geimonen et al.,
2002). We have also demonstrated that many of these cellular
responses are virus replication dependent (Khaiboullina et al.,
2004; Khaiboullina et al., 2005). While the precise mechanism by
which hantaviruses activate these cellular responses remains
unknown, it is likely that they are mediated through nuclear
factor κ-light-chain-enhancer of activated B cells (NF-κB) and
interferon regulatory factor-3 (IRF-3) (Khaiboullina et al., 2005;
Sundstrom et al., 2001).
Pro-myelocytic leukemia nuclear bodies (PML-NBs) are nuclear
sub-structures associated with the nuclear matrix, which have
been implicated in numerous cellular processes, including tran-
scription, post-translational modiﬁcations, oncogenesis, innate
immunity and several antiviral responses (Grisendi et al., 2005;
Borden 2002). The composition of PML-NBs is heterogeneous and
includes constitutively expressed essential constituents such as
pro-myelocytic leukemia protein (PML), interferon-stimulated
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and really-interesting-new-gene (RING)-ﬁnger proteins (Borden
et al., 1998; Melchior 2000; Maul et al., 2000). The expression of
PML has been observed in all mammalian tissues and cell lines
thus far investigated (Flenghi et al., 1995; Terris et al., 1995). At
least seven isoforms have been described based on alternative
splicing of the C-terminal exons, all of which contain the ﬁrst three
exons that encode the RBCC/TRIM motif (Jensen et al., 2001). The
majority of PML isoforms (I-VI) have nuclear localization signal
(NLS) that regulate their incorporation into NBs (Jensen et al.,
2001; Melnick and Licht 1999); however, PML VII lacks this signal
and subsequently, is conﬁned to the cytoplasm (Flenghi et al.,
1995; Fagioli et al., 1992).
PML-NBs are macromolecular complexes of helicases and tran-
scription factors that are important sites for transcriptional control
(Maul et al., 2000; Nefkens et al., 2003). The interaction between
PML-NBs and viruses is complex. It has been shown that PML-NBs
can facilitate replication of several DNA viruses by providing the sites
for genomic replication (Maul 1998). Additionally, multiple reports
conﬁrm that PML-NBs become disrupted and reorganized during the
early stages of viral infection (Puvion-Dutilleul et al., 1995). Although
it is therefore apparent that PML-NBs play important roles in both
supporting virus replication and the establishment of innate antiviral
responses, the exact processes are not characterized. As such, here
we investigated the impact of hantavirus infection on various nuclear
pathways including PML and its direct involvement in apoptosis.Fig. 2. Effect of ANDV and HTNV infection on PML expression in HUVECs. A.
Western blot. HUVECs were infected with ANDV and HTNV at MOI of 1. Total
proteins were collected at 72 hours PI and used to determine PML expression in
Western blot. Mock infected HUVECs were used as a control. Mon anti-PML
antibodies were used to determine PML expression. B. Fluorescence pixel intensity.
Control mock-infected HUVECs; ANDV infected HUVECs; HTNV
infected HUVECs.Results
Hantavirus infection activates PML in HUVEC cells in vitro
Previously, we have shown that hantavirus infection activates
cellular responses in HUVECs (Khaiboullina et al., 2004).
Interferon-inducible genes were found to be activated in hanta-
virus infected HUVECs early after infection (Khaiboullina et al.,
2004; Geimonen et al., 2002). Activation of cellular responses may
be mediated, at least in part, through the induction of cytoplasm-
to-nucleus translocation of low-abundance regulatory proteins
(Khaiboullina et al., 2005; Sundstrom et al., 2001). It has been
shown that PML expression becomes upregulated by interferon
and participates in establishing the interferon-induced antiviral
state in host cells (Regad and Chelbi-Alix 2001; Regad et al., 2001;
Chelbi-Alix et al., 1995; Chelbi-Alix et al., 1998). Therefore, we
sought to determine whether PML is activated in hantavirus
infected HUVECs.
HUVEC monolayers were infected with ANDV and HTNV at an
MOI of 1. Infected monolayers (72 hours PI) were ﬁxed and
incubated with monoclonal anti-PML and rabbit-anti-ANDV N
protein antibodies. A small number and low intensity PML-NBsFig. 1. PML activation in ANDV and HTNV infected HUVECs. HUVECs monolayers were in
incubated with Mon anti-PML and rabbit anti-ANDV N protein serum. Anti-mouse-Alexa
respectively. A – Mock-infected HUVECs monolayer; B – ANDV infected HUVECs monolawere found in mock-infected control HUVECs at 72 hours PI
(Fig. 1A). However, the number of PML-NBs and their ﬂuorescent
intensity were substantially increased in ANDV- and HTNV-
infected HUVECs when compared to mock-infected cells (Fig. 1B,
C). Activation of PML in hantavirus infected HUVECs was further
conﬁrmed by using western blot (Fig. 2A) and ﬂuorescence pixel
intensity detection (Fig. 2B).Sp100 but not DAXX co-localizes with PML in hantavirus infected
HUVECs
PML activation induces nuclear translocation of Sp100 and
DAXX proteins and their co-localization in NBs (Bell et al., 2000).fected with ANDV and HTNV with MOI of 1 for 72 hours. Monolayers were ﬁxed and
488 and anti-rabbit-Alexa-555 were used to visualize PML and hantavirus antigens
yers; C – HTNV infected HUVECs monolayers.
Fig. 3. Subcellular localization of PML and SP100 in ANDV and HTNV infected HUVECs. HUVECs monolayers were infected with ANDV and HTNV with MOI of 1 for 72 hours.
Monolayers were ﬁxed and incubated with Mon anti-PML and rabbit anti-SP100 antibodies. Anti-mouse-Alexa 488 and anti-rabbit-Alexa-555 were used to visualize PML
and SP100 respectively. A – intracellular localization of PML in mock infected HUVECs; B – intracellular localization of SP100 in mock infected HUVECs; C – merged image
from slides A and B; D - intracellular localization of PML in ANDV infected HUVECs; E - intracellular localization of SP100 in ANDV infected HUVECs; F - merged image from
slides D and E; G – intracellular localization of PML in HTNV infected HUVECs; H – intracellular localization of SP100 in HTNV infected HUVECs; I – merged image from slides
G and H.
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localized with Sp100 and DAXX in hantavirus infected HUVECs.
HUVEC monolayers were infected with ANDV and HTNV at an
MOI of 1. Mock-infected HUVEC monolayers were used as a
control. Monolayers were ﬁxed at 72 hours PI and probed with
antibodies against PML/Sp100 and PML/DAXX proteins, (Fig. 3 and
4). PML and Sp100 were co-localized in HUVECs infected with
ANDV and HTNV (Fig. 3). Surprisingly, only a minor portion of PML
was found in proximity to the nuclear staining that were con-
sidered positive for DAXX (Fig. 4).PML is closely associated with interferon-stimulated gene 20 kDa
protein (ISG-20) in hantavirus infected HUVECs
Previously, we have reported transcriptional activation of ISG-
20 in hantavirus infected HUVECs (Khaiboullina et al., 2004). ISG-
20 is known as interferon-inducible protein closely associated
with PML-NBs (Gongora et al., 1997). Nuclear co-localization of
PML with many interferon-activated proteins, including ISG-20,
has been suggested to play important role in establishing and
maintaining interferon-dependent antiviral defense (Gongoraet al., 1997). Therefore, we sought to determine whether hanta-
virus infection inﬂuences ISG-20 nuclear localization in HUVECs.
HUVECs were infected with ANDV and HTNV at an MOI of
1 and used to determine ISG-20 and PML localization (Fig. 5).
ANDV and HTNV infection up-regulated expression of PML and
ISG-20 in hantavirus infected HUVECs at 72 hours PI. Both proteins
were localized in the nucleus; however, ISG-20 was distributed
throughout the nucleus and closely associated (rather than per-
fectly overlapped) with the PML-NBs (Fig. 5D, G). Activation of ISG-
20 during hantavirus infection was also conﬁrmed by western
blotting. Total proteins were collected at 72 hours PI and used to
determine ISG-20 protein expression. Our data demonstrated that
ANDV and HTNV infection upregulates ISG-20 expression in
HUVECs at 72 hours PI (Fig. 6).
Hantavirus replication is required for PML activation in HUVECs
HUVECs were infected with either infectious or inactivated
(gamma-irradiated) ANDV or HTNV at MOI of 1. Accumulation of
the ANDV and HTNV S genome segment RNA was used to measure
efﬁciency of replication of infectious and gamma-radiated hanta-
viruses. Total RNAwas collected 72 hours PI and used to determine
Fig. 4. Subcellular localization of PML and DAXX in ANDV and HTNV infected HUVECs. HUVECs monolayers were infected with ANDV and HTNV with MOI of 1 for 72 hours.
Monolayers were ﬁxed and incubated with Mon anti-PML and rabbit anti-DAXX antibodies. Anti-mouse-Alexa 488 and anti-rabbit-Alexa-555 were used to visualize PML and
SP100. A – intracellular localization of PML in ANDV infected HUVECs; B – intracellular localization of SP100 in ANDV infected HUVECs; C – merged image from slides A and B;
D – intracellular localization of PML in HTNV infected HUVECs; E – intracellular localization of SP100 in HTNV infected HUVECs; Merged image from slides D and E.
Fig. 5. Effect of ANDV and HTNV infection on ISG-20 expression in HUVECs.
HUVECs were infected with ANDV and HTNV at MOI of 1. Total proteins were
collected at 72 hours PI and used to determine ISG-20 expression in Western blot.
Mock infected HUVECs were used as a control. Rabbit anti-ISG-20 antibodies were
used to determine ISG-20 expression.
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tion of S segment RNA of ANDV and HTNV was signiﬁcantly
decreased in HUVECs infected with irradiated ANDV and HTNV,
when compared to infectious ANDV and HTNV (Fig. 7A, B).
The effect of hantavirus replication on PML activation was
determined using immunoﬂuorescence. HUVEC monolayers were
inoculated with infectious or gamma irradiated ANDV and HTNV
and then incubated with anti-PML and anti-ANDV N protein
antibodies. Mock-infected HUVEC monolayers were used as a
control. An increased intensity of staining for PML was found only
in HUVECs exposed to infectious ANDV and HTNV (Fig. 8). How-
ever, the number of PML-NBs (and the signal intensity) in HUVECs
exposed to gamma radiation inactivated ANDV or HTNV did not
differ from that in mock-infected HUVECs (Fig. 8).PML activation requires hantavirus protein expression
PML, Sp100, and ISG-20 belong to the group of interferon-
inducible proteins. Previously, we have shown that hantavirus
infection does not activate interferon gene expression in HUVECs
(Khaiboullina et al., 2004). Therefore, we sought to determine
whether accumulation of viral transcripts and/or proteins could
activate PML in hantavirus infected cells. A549 cells were utilized
in these experiments. A549 cells were selected as they support
hantavirus replication and activate interferon inducible genes
similar to those up-regulated in hantavirus infected HUVECs.
PML belongs to the group of interferon inducible genes and
considered to be a mediator within the antiviral pathway rather
than as a direct effector protein (Djavani et al., 2001; Bonilla et al.,
2002). Therefore, we expected that the pattern of PML activation
in A549 cells will be similar to that in HUVECs. To determine
whether accumulation of hantavirus proteins is required for PML
activation, A549 cells were treated with cycloheximide (CXM;
100 ng/ml; 6 h at 37 1C, 5% CO2) prior to infection with ANDV
(MOI of 1). Total RNA and proteins were collected at 72 hours PI to
determine accumulation of the virus S segment RNA and the N
protein, respectively. Additionally, A549 cell monolayers treated
with CXM were infected with ANDV and HTNV for 72 h.
Fixed monolayers were incubated with monoclonal anti-PML and
rabbit anti-ANDV N protein antibodies. As expected, CXM treat-
ment inhibited ANDV N protein accumulation in A549 cells at 72 h
PI when compared to the untreated cells (Fig. 9A). However,
CXM treatment did not affect accumulation of the ANDV S
segment RNA (Fig. 9B). CXM treatment did not affect PML nuclear
localization and distribution in un-infected A549 cells. This
could be explained by the nuclear translocation of the exist-
ing cytoplasmic PML (Mattsson et al., 2001). Nevertheless,
PML-NB activation was detected only in cells infected with
ANDV but without CXM treatment (Fig. 9C). These results suggest
that the presence of hantavirus proteins is essential for PML
activation.
Fig. 6. Subcellular localization of PML and ISG-20 in ANDV and HTNV infected HUVECs. HUVECs monolayers were infected with ANDV and HTNV with MOI of 1 for 72 hours.
Monolayers were ﬁxed and incubated with Mon anti-PML and rabbit anti-ISG-20 antibodies. Anti-mouse-Alexa 488 and anti-rabbit-Alexa-555 were used to visualize PML
and SP100 respectively. A – intracellular localization of ISG-20 in mock infected HUVECs; B – intracellular localization of PML in ANDV infected HUVECs; C – intracellular
localization of ISG-20 in ANDV infected HUVECs; D - merged image from slides B and C; E - intracellular localization of PML in HTNV infected HUVECs; F - intracellular
localization of ISG-20 in HTNV infected HUVECs; G – merged image from slides E and F.
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Post-translational modiﬁcation of PML by covalently attaching
SUMO (sumoylation) is required for various cellular processes,
such as nuclear-cytosolic transport and transcriptional regulation.
It has been shown that SUMO modiﬁcation of PML is necessary for
its co-localization with proteins of the NB. Therefore, we examined
whether PML undergoes sumoylation in hantavirus infected A549
cells. A549 cell monolayers were infected with ANDV at MOI of 1.
Mock-infected A549 cell monolayers were used as a control.
Monolayers were ﬁxed at 72 h PI and used to determine localiza-
tion of PML and SUMO. Although PML was localized in the nucleus
of ANDV infected cells, SUMO protein remained predominantly in
the cytoplasm (Fig. 10B, C).
It has been shown that hantavirus N protein is co-localized
with SUMO in the cytoplasm (Kaukinen et al., 2003; Maeda et al.,
2003). Furthermore, it was found that hantavirus N protein is
SUMO modiﬁed (Kaukinen et al., 2003; Maeda et al., 2003).
Therefore, we sought to determine, whether ANDV N protein
interacts with SUMO using immunoﬂuorescence methods. ANDV
N protein was found co-localized with SUMO in cytoplasm of
infected A549 cells (Fig. 10A). Interaction between SUMO andANDV N protein was further conﬁrmed using the immunoprecipi-
tation assay (Fig. 11). ANDV infected A549 cell lysates were
collected under non-denaturing conditions and incubated with
rabbit anti-SUMO antibodies. Antigen-antibody complexes were
analyzed using western blotting using anti-PML or anti-ANDV N
monoclonal antibodies (Fig. 11). We have found that ANDV N
protein was immunoprecipitated by using anti-SUMO antibodies
(Fig. 11; IA, line 2). However, ANDV infection did not affect the
amount of PML protein immunoprecipitated by SUMO; it
remained similar between mock infected and ANDV infected
A549 cells (Fig. 11; IIA, line 1 and 2, respectively).Discussion
Using DNA microarray assays, we have previously shown that
hantavirus infection activates cellular responses in HUVECs in vitro
(Khaiboullina et al., 2004). However, the mechanisms of hanta-
virus induced cellular gene activation remain unknown. DNA
microarray analyses may not be suitable for investigating the
mechanisms of cellular gene activation because activation of many
transcription activation factors requires post-translational
Fig. 7. Gamma radiation inhibits hantavirus replication in HUVECs. HUVECs were
infected with infectious and gamma irradiation inactivated ANDV and HTNV with
MOI of 1. Total RNA was collected at 1, 3, 24, and 72 hours PI. TaqMan was
performed using TaqMan MGB probes on an ABI Prism 7000 Sequence Detection
System. Standard curves for relative quantitation of ANDV and HTNV S segment
RNA and 18S RNA were created using serial dilutions of cDNA from infected and
uninfected control samples respectively. All TaqMan reactions were performed in
duplicate. A – ANDV S segment RNA accumulation in HUVECs infected with
infectious and gamma-irradiated ANDV; B - HTNV S segment RNA accumulation
in HUVECs infected with infectious and gamma-irradiated HTV. - S segment
RNA accumulation in HUVECs infected with irradiated hantavirus; - S
segment RNA accumulation in HUVECs infected with infectious hantavirus.
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others, has reported activation of NF-κB and IRF-3 in hantavirus
infected cells (Khaiboullina et al., 2005; Sundstrom et al., 2001).
However, the upregulation of functionally diverse group of genes
suggests activation of various transcription activation factors in
hantavirus infected endothelial cells.
PML is an essential component of the subnuclear structures
known as PML-NBs. These structures are implicated in a wide
range of cellular responses. Ablation and over-expression experi-
ments suggest an important role of PML in regulation of cell
growth, hematopoietic cell differentiation, transcription, post-
translational modiﬁcations, oncogenesis, DNA damage repair,
apoptosis, senescence, p53 regulation, telomere maintenance,
innate immunity and antiviral responses (Mu et al., 1997; Wang
et al., 1998).
Recent studies have demonstrated that some viruses utilize
PML-NBs for their replication in host cell. For example, it has been
shown that early transcription and genome replication of several
viruses including herpesviruses, adenoviruses, and simian virus 40
occur in proximity to PML-NBs (Maul 1998; Everett 2001). In
addition, newly synthesized RNA is found associated with the
periphery of the PML-NBs suggesting that peripheries of PML-NBs
are sites of transcription for particular genes (Boisvert et al., 2000).
Although the role of PML-NBs in replication of DNA viruses is well
established, recently, it has been shown that PML-NBs are
activated in cells infected with RNA viruses replicating strictly in
the cytoplasm. For example, Lassa fever virus and lymphocyticchoriomeningitis virus (LCMV) actively interact with PML-NBs
(Borden et al., 1998; Kentsis et al., 2001). Redistribution of PML
and Sp100 from PML-NBs into the cytoplasm was also demon-
strated in cells infected with respiratory syncytial virus (Brasier
et al., 2004). Additionally, over-expression of different PML iso-
forms has been shown to inhibit replication of RNA viruses, such as
rhabdovirus, vesicular stomatitis virus (VSV) (Chelbi-Alix et al.,
1998), and the retrovirus human foamy virus (HFV) (Regad et al.,
2001). These data implicate PML involvement in the host antiviral
response against RNA viruses.
Consistent with previous reports, our data demonstrate that
hantavirus infection activates PML in HUVECs in vitro. We have
shown that the number and intensity of PML-NBs was increased in
HUVECs infected with ANDV and HTNV as early as three hours PI,
and remained upregulated up to 72 h PI. Our results suggest a
novel mechanism for activation of cellular responses in hantavirus
infected cells in addition to NF-κB and IRF-3 pathways
(Khaiboullina et al., 2005; Sundstrom et al., 2001). Furthermore,
our ﬁndings indicate that hantavirus infection activates NB pro-
teins, even though viral transcription and replication occur
entirely in cytoplasm. Upregulation of PML in hantavirus-
infected cells requires hantavirus replication and, in particular,
hantavirus protein synthesis.
We observed PML co-localization with Sp100 protein in hanta-
virus infected HUVECs. These proteins are transcription regulation
factors essential for the NBs formation (Lamond and Earnshaw
1998; Seeler et al., 1998). In addition, Sp100 interacts with
heterochromatin protein 1 (HP1), which functions as a transcrip-
tional repressor (Seeler et al., 1998). In addition, Sp100 acts as a
repressor of transcription when tethered to DNA (Seeler et al.,
1998; Lehming et al., 1998). It has been shown recently that Sp100
negatively regulates ETS1 transcriptional activities (Yordy et al.,
2004; Yordy et al., 2005). For example, Sp100 upregulates the
expression of proteins with anti-migratory and anti-angiogenic
activity that are suppressed by ETS1 (Yordy et al., 2004; Yordy
et al., 2005). Therefore, it is reasonable to propose that when
located in NBs together with PML, Sp100 regulates transcriptional
activity in the nucleus of hantavirus infected HUVECs.
It has been suggested that SUMO-1 modiﬁcation of PML is not
required for its localization to NBs (Maul et al., 2000). However,
SUMO-1 modiﬁcation is essential for recruitment of DAXX into the
NBs (Ishov et al., 1999). It appears that the level of SUMO-1
modiﬁcation of PML may determine the amount of DAXX recruited
into NBs (Maul et al., 2000). We have shown that upregulation of
PML in hantavirus infected cells does not increase its SUMO-1
modiﬁcation. Furthermore, our data have demonstrated that
upregulated PML does not co-localize with DAXX. In fact, PML
immunoreactivity was strictly localized around DAXX and only a
small portion of PML and DAXX immunoreactivity was found in
proximity to each other. We propose that since DAXX is not
localized in PML-NBs this might be due to the fact that PML
remained un-sumoylated in hantavirus infected cells. It is known
that DAXX localization in NBs is essential for its pro-apoptotic
activity. For example, PML interaction with DAXX is required for
the enhancement of Fas-induced apoptosis (Torii et al., 1999).
Likewise, DAXX mutants that fail to localize with NBs are unable to
facilitate Fas-induced cell death (Torii et al., 1999). Furthermore, in
the absence of PML, DAXX ability to activate cell death is
diminished (Zhong et al., 2000). These ﬁndings indicate that DAXX
and PML, when co-localized in the NBs, may cooperate to mediate
apoptosis. Our group, as well as others, has shown previously that
hantavirus infection does not cause apoptosis in HUVEC cells
(Khaiboullina et al., 2000; Khaiboullina et al., 2004; Sundstrom
et al., 2001; Pensiero and Hay 1992). One could suggest that
hantaviruses do not cause apoptosis in the infected cells because
upregulated PML is not SUMO-1 modiﬁed, thus preventing DAXX
Fig. 8. Effect of ANDV and HTNV replication on PML activation in HUVECs. HUVECs monolayers were infected with infectious and gamma irradiated ANDV and HTNV with
MOI of 1 for 72 hours. Monolayers were ﬁxed and incubated with Mon anti-PML and rabbit anti-ANDV N protein antibodies. Anti-mouse-Alexa 488 and anti-rabbit-Alexa-
555 were used to visualize PML and hantavirus N protein respectively. A – PML in mock-infected HUVECs; B – PML and ANDV N protein in HUVECs infected with gamma
radiated ANDV; C – PML and HTNV N protein in HUVECs infected with gamma radiated HTNV; D – PML and ANDV N protein in HUVECs infected with ANDV; E – PML and
HTNV N protein in HUVECs infected with HTNV.
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this hypothesis.
PML gene belongs to the family of interferon-stimulated genes
(ISG), because the number and the intensity of PML-NBs increase
in response to IFN treatment (Lavau et al., 1995; Grotzinger et al.,
1996; Nason-Burchenal et al., 1996). Over-expression of PML
induces resistance to infections by vesicular stomatitis and inﬂu-
enza A viruses (Chelbi-Alix et al., 1995; Iki et al., 2005). The fact
that many viruses disrupt the integrity of PML-NBs, suggest the
importance of PML in activation of an antiviral state in cells (Chee
and Roizman 2004; Nicewonger et al., 2004; Evans and Hearing
2003; Blondel et al., 2002). Studies have suggested that PML most
likely acts as a mediator within the antiviral pathway rather than
as a direct effecter protein (Djavani et al., 2001; Bonilla et al.,
2002). Our group, as well as others, has shown that hantavirus
infection activates a number of INF-inducible genes in HUVECs
(Khaiboullina et al., 2004; Geimonen et al., 2002; Khaiboullina
et al., 2005). Previously we reported that hantavirus infection
activates IRF-3, one of the INF-inducible gene transcription activa-
tion factors (Khaiboullina et al., 2005). Activation of PML in
hantavirus infected HUVECs presents an additional pathway
which can potentially be utilized to activate INF-inducible genes
in HUVECs.
Previously, we reported that hantavirus infection activates ISG-
20 gene expression in hantavirus infected HUVECs (Khaiboullina
et al., 2004). ISG-20 is an interferon inducible protein closely
associated with PML-NBs (Gongora et al., 1997). This study
demonstrates that ISG-20 expression is up-regulated in hantavirus
infected HUVECs. Additionally, we have found that ISG-20 is
localized in the nucleus and closely associated with PML. ISG-20
is the second known RNase regulated by IFN, along with RNase L
(Nguyen et al., 2001; Espert et al., 2003). We have also reported
that hantavirus infection activates MxA, another interferon indu-
cible protein, in HUVECs (Khaiboullina et al., 2005). Our datademonstrates ISG-20 activation in hantavirus infected cells sug-
gesting an additional antiviral mechanism activated in HUVECs.Materials and methods
Cell culture
Human umbilical vein endothelial cells (HUVECs), Vero clone
E6 (Vero E6), and A549 (type II lung epithelial cells) were obtained
from ATCC. HUVECs were grown in MCDB 131 medium supple-
mented with human vascular endothelial cell growth factor,
hydrocortisone, 2% fetal bovine serum (FBS), human ﬁbroblast
growth factor (0.5 ml; 1 μg/ml), ascorbic acid, heparin (0.5 ml;
1 μg/ml), and gentamycin (Clonetics). Cells were used between
passages 2 to 4. A549 and Vero E6 cells were grown in DMEM
medium containing 20% FBS and 50 μg/ml gentamycin.Virus
Andes virus strain 23 (ANDV) and Hantaan virus strain 76–118
(HTNV) (gift of Dr. Thomas G. Ksiazek, Special pathogens Branch, CDC)
were used in this study. Viral stocks (3–6105 plaque-forming units/
ml (pfu)) were prepared using Vero E6 cells and stored at −80 1C. In
our experiments, cells were infected at multiplicity of infection (MOI)
1 (virus to cell ratio of 1:1). Virus was allowed to attach to the cells for
1 hour at 37 1C in a 5% CO2 atmosphere. Non-attached virus was
removed by washing the cells with Hank's balanced salt solution
(HBSS) and new medium was subsequently added. Cells were
harvested at 24, 48, and 72 hours post-infection (PI) for protein
extraction and at 1, 3, 24, and 72 hours PI in Trizol for total RNA
extraction and stored at −80 1C. Mock-infected cells were used as a
control for all experiments, and as an additional control in some
Fig. 9. Effect of hantavirus protein replication on PML activation. A549 cells were treated with CXM (100 ng/ml; 6 h at 37 1C, 5% CO2) prior ANDV infection (MOI of 1.0). Total RNA and
proteins were collected 72 hours PI to determine viral S segment RNA and N protein accumulation respectively. Additionally, A549 cell monolayers treated with CXM were infected
with ANDV for 72 h. Fixed, monolayers were incubated with Mon anti-PML and rabbit anti-ANDV N protein antibodies. I – CXM effect on ANDV protein expression in A549 cells; 1 –
ANDV infected A549 cells treated with CXM 2 – ANDV infected A549 cells without treatment A – ANDV N protein; B – actin. II –CXM effect on ANDV S segment RNA accumulation in
A549 cells; ANDV S segment RNA accumulation in A549; ANDV S segment RNA accumulation in A549 cells treated with CXM. III – Immunohistochemistry of CXM effect on
ANDV caused PML activation in A549 cells. A – PML in mock infected control A549 cells; B – PML in ANDV infected A549 cells; C – PML and ANDV N protein in A549 cells; D – PML in
CXM treated mock infected A549 cells; E - PML in CXM treated ANDV infected A549 cells; F – PML and ANDV N protein in CXM treated ANDV infected A549 cells.
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also used to infect HUVECs.
Immunoﬂuorescence
HUVEC monolayers were infected with each hantavirus strain
at an MOI of 1. Cell monolayers (72 hours PI) were ﬁxed in
methanol:acetone (3:1) for 5 min at room temperature. Slides
were next washed with PBS (pH 7.4); incubated with glycine
buffer (10 mM glycine in PBS pH 7.4; 30 min) and permeabilized
with 0.1% Triton X100 for 30 min. Slides were then washed three
times with PBS (pH 7.4) and incubated with the respective
mixtures of primary monoclonal (mAB) or polyclonal antibodies
(Table 1) for 30 minutes at room temperature.
After incubation with the respective antigen-speciﬁc primary anti-
bodies, monolayers were washed three times with PBS (pH 7.4) andincubated with the appropriate ﬂuorescently labeled secondary anti-
bodies for 30min at room temperature in the dark (Table 1). Slides
were ﬁnally washed three times with PBS (pH 7.4) and examined by
ﬂuorescentmicroscopy (Nikon C1). Imageswere processed using Nikon
EZ-C1 software and the ﬂuorescence pixel intensity was determined
for randomly selected ﬁelds of focus for quantitative analysis.Real-time PCR (RT-PCR)
Oligonucleotide primers and ﬂuorogenic probes for RT-PCR (TaqMan)
TaqMan Minor Groove Binder (MGB) ﬂuorogenic probes and
primers were designed using Primer Express software (Applied
Biosystems) according to the manufacturers instructions as described
previously (Rizvanov et al., 2004). The sequences of the primers and
probes for the ANDV and HTNV S genome segment are summarized in
Fig. 10. Subcellular localization of PML, SUMO, and ANDV N protein in HUVECs. HUVECs monolayers were ANDV infected with MOI of 1. Monolayers were ﬁxed (72 hours PI)
and incubated with Mon anti-PML, rabbit anti-SUMO, and rabbit anti-ANDV N protein antibodies. Anti-mouse-Alexa 488 and anti-rabbit-Alexa-555 were used to visualize
PML, SUMO, and ANDV N protein. A – ANDV N protein and SUMO co-localization in ANDV infected HUVECs; B – PML and SUMO localization in ANDV infected HUVECs; C –
PML and SUMO localization in mock-infected HUVECs.
Fig. 11. PML and ANDV S segment interaction with SUMO. A549 cells were infected
with ANDV at MOI of 1. Total proteins were collected at 72 hours PI and used to
incubate with Anti-SUMO antibodies. Antibody-protein complexes were separated
in SDS-gel and incubated with mouse-anti-PML or Mon anti-PUU N protein
antibodies. I – ANDV N protein II – PML A – Immunoprecipitation; B – SDS-gel
A549 cells; C – SDS-gel 18 S 1 – mock-infected A549 cells; 2 – ANDV infected
A549 cells.
Table 1
Antibodies used for PML, SP100, ISG-20, DAXX, and hantavirus N protein intracel-
lular localization.
Co-localization Pair of antibodies
PML-SP100 Mon anti-PML (1:100;
Santa Cruz)
Rabbit anti-SP100
(1:100; Santa Cruz)
PML-DAXX Mon anti-PML (1:100;
Santa Cruz)
Rabbit anti-DAXX
(1:100; NeoMarkers)
PML-ISG-20 Mon anti-PML (1:100;
Santa Cruz)
Rabbit anti-ISG-20
(1:5,000)
Table 2
Primers and probes for TaqMan Real-Time PCR.
Target gene Forward primer Reverse primer TaqMan probe
ANDV S tcacgccaggacgatttagg ggctttgacctgtgctggaa caattgcttgtggcctt
HTV S gcagcagttagcctccttggt tgccgctgccgtaagtagt tcctgcaacaaacagg
S.F. Khaiboullina et al. / Virology 443 (2013) 338–348346Table 2. Primers were obtained from Invitrogen (Carlsbad, CA) and
probes were synthesized by ABI (Applied Biosystems).cDNA synthesis
For cDNA synthesis, an RNA/primer mix of 1 ul RNA, 1 ul of
random hexamer primers (Invitrogen) and 8.5 ul of H2O was
denatured at 70 1C for 10 min and chilled quickly to 4 1C. cDNA
was synthesized by adding 1 ul of each dNTP (10 mM; GIBCO),
1RT buffer (Promega), 200 U of M-MLV RT (Promega), and 20 U
of rRNasin RNase inhibitor (Promega) in a 20 ml volume of reaction
mix. After incubation for 10 min at 25 1C, the reaction proceeded
for 1 hour at 42 1C and was terminated by heating at 95 1C for
5 min. cDNA was stored at −20 1C.RT-PCR TaqMan reaction
Samples were evaluated by RT-PCR using an ABI Prism 7000
Sequence Detection System. Each PCR reaction (25 μl) consisted of
1 μl of cDNA, 1х Platinum qPCR Supermix-UDG (Invitrogen),
200 nM of each primer, and 100 nM of probe. 18 S ribosomal
RNA was used as an internal control according to the manufac-
turer's instructions. cDNA samples were diluted 1:1000 with
nuclease free water before use in 18S ribosomal RNA speciﬁc RT-
PCR reactions. Standard curves for relative quantitation of the
ANDV and HTNV S genome segment RNA and the 18S RNA were
created using serial dilutions of cDNA from infected and unin-
fected control samples depending upon speciﬁcs of the experi-
mental design. All RT-PCR reactions were performed in duplicate.
RT-PCR values of the ANDV and HTNV S genome segment RNA
were normalized against RT-PCR values of the 18S ribosomal RNA
expression from a corresponding sample. Normalized values were
expressed as relative values to the same RNA expressed in the
corresponding control sample.
Western blotting
Hantavirus infected cells were lysed in 200 μl (106 cell/40 μl) of
a 1% solution of sodium dodecyl sulfate (SDS), and analyzed by
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE). Equivalent loading of each lane of the SDS-PAGE was
achieved by quantitation of the protein using modiﬁed Lowry
protein assay (Pierce) and was veriﬁed by coomassie blue staining
of the gel. Proteins were electroblotted (15 min, 4 mA/cm2) onto
nitrocellulose membranes (Bio-Rad) and blocked for 1 hour at
room temperature with 5% non-fat dry milk in Tris-buffered saline
(TBS) and 0.5% Tween 20. After three washes, membranes were
incubated (18 hours, 4 1C) with the monoclonal anti-PML antibody
(Santa-Cruz; 1:100), anti-ISG-20 rabbit antibodies (Gift of Dr.
Mechti; 1:5,000), and rabbit anti-ANDV N protein polyclonal
serum (1:100). Antigen-antibody complexes were identiﬁed with
goat anti-rabbit IgG-HRP or goat anti-mouse IgG-HRP conjugated
antibodies (Vector Laboratories) and developed using the Vector
Laboratories HRP (horseradish peroxidase) substrate kit according
to the manufacture's instructions. In some experiments, expres-
sion of proteins was presented relative to expression of the β-actin
protein in the corresponding sample.
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A549 cells were infected with ANDV at an MOI of 1 or mock
infected. At 72 hours PI, cells were harvested in cell lysate RIPA
buffer (150 mM NaCl, 10 mM Tris, pH 7.2, 0.1% SDS, 1% Triton
X-100, 1% Deoxycholate, and 5 mM EDTA) containing protease
inhibitor cocktail (Roche). Lysates were precleared by centrifuga-
tion and nonspeciﬁc protein binding was absorbed by incubation
with normal rabbit antibodies and protein G-Plus (Pierce) for
1 hour at 4 1C. 500 μl of precleared and absorbed lysate were
incubated with rabbit antibodies against small ubiquitin-related
modiﬁer protein (SUMO) (Santa Cruz) for 2 hours at 4 1C. Protein
G-Plus beads (50 μl) were then added and the incubation con-
tinued overnight. The immune complexes were pelleted and
washed four times with RIPA buffer. Sample buffer (6 μl) was then
added to each pellet and boiled for 7 min and analyzed using 10%
SDS-PAGE. Monoclonal anti-PML and monoclonal anti-PUU N
protein antibodies were used to detect PML and the ANDV N
protein, respectively.
Statistical analysis
Statistical analysis was performed using Student's t-test for
comparisons between individual experimental groups (infected
and non-infected). Signiﬁcance was established at a value of
Po0.05. Data are presented as Mean7Standard Error.Statement of interest
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